Pharvaris publishes review on bradykinin B2 receptor as therapy target

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/25/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. SPY
7. TMUS
8. UNP
9. GOOGL
10. RNG

Go back to Pharvaris publishes review on bradykinin B2 receptor as therapy target
(NASDAQ: PHVS) Delayed: 34.17 +0.91 (2.74%)
Previous Close $33.26    52 Week High $ 
Open $33.59    52 Week Low $ 
Day High $34.38    P/E N/A 
Day Low $33.33    EPS $ 
Volume 255,708